Cardiovascular disease remains one of the most significant health challenges facing employers, affecting employee well-being, workforce productivity, and healthcare costs. As organizations continue to navigate rising medical spend and increasing rates of chronic conditions, many employers are taking a closer look at cardiac risk and how earlier intervention may improve outcomes while managing long-term healthcare costs.
While many organizations already address common cardiovascular risk factors such as high blood pressure, high cholesterol, diabetes, and obesity, traditional approaches may not always identify individuals who are developing heart disease. Cardiovascular disease can progress silently, and some individuals who appear healthy or lack common risk factors may still experience a cardiac event. This creates an opportunity for employers to think more broadly about prevention and early risk identification.
In our July Health Risk Management webinar, Meesha Dogan, PhD, founder and CEO of Cardio Diagnostics, explored why cardiovascular disease deserves greater attention within employer health strategies. Drawing on clinical research, claims analysis, and emerging approaches to cardiac risk assessment, Dogan examined the human and financial impact of cardiovascular disease, limitations of traditional risk indicators, and practical strategies employers can consider to identify and address risk earlier.
The session reinforced that managing cardiovascular risk requires more than responding to diagnosed disease — it requires a coordinated strategy that helps employers understand their populations, identify potential risk earlier, and connect employees with appropriate resources before conditions and costs escalate.
Heart disease remains the leading cause of death in the United States for both men and women, and its financial impact extends beyond the initial cardiac event. According to Dogan, one claims analysis presented during the webinar, medical costs for an individual experiencing a cardiac event or diagnosis were approximately 10 times higher than those of a matched peer during the year of diagnosis. Costs remained elevated the following year as ongoing management, follow-up care, and medications continued.
Cardiovascular disease can progress silently, making it difficult to identify through symptoms or common risk factors alone. As Dogan noted in the webinar, one in five heart attacks is considered silent, and claims analysis presented during the webinar found that approximately half of individuals diagnosed with coronary heart disease or experiencing a heart attack had none of the common risk factors. Blood pressure, cholesterol, blood glucose, and other indicators remain valuable, but they may not tell the full story of an individual’s cardiovascular risk.
While genetics plays a role in cardiovascular disease, Dogan noted that inherited genetic variation accounts for less than 20% of overall cardiovascular risk. Lifestyle and environmental factors — including diet, physical activity, smoking, stress, sleep, and environmental exposures — can influence how risk develops over time. Because many of these factors are modifiable, earlier identification creates opportunities to intervene before the disease progresses.
Analyzing medical and pharmacy claims over multiple years can help employers better understand cardiovascular and cardiometabolic trends within their populations. Reviewing prevalence, comorbidities, utilization patterns, sites of care, and costs can reveal where risk and spending are concentrated. These insights can help employers identify populations that may benefit from additional support and take a more targeted approach to prevention and chronic condition management.
Cardiovascular disease is closely connected with chronic conditions, including hypertension, obesity, diabetes, chronic kidney disease, high cholesterol, depression, and stress. Rather than managing these conditions or individual health solutions in isolation, employers can consider how their programs work together. Incorporating upstream risk identification can help direct employees toward appropriate resources earlier, while evaluating engagement, integration, and outcomes can help employers build a more cohesive health strategy.
For employers participating in Medical Stop Loss (MSL) group captives, proactively addressing cardiovascular risk can support both employee health and long-term plan performance.
Cardiac events can lead to significant claims and ongoing healthcare costs, while cardiovascular risk may not always be evident through traditional indicators. Greater transparency into claims data available through an MSL group captive can help members identify emerging trends and opportunities for earlier intervention, enabling them to implement more targeted strategies for prevention and chronic condition management.
By combining these data-driven insights with shared strategies and best practices, captive members can support better health outcomes while helping manage long-term healthcare costs.
This presentation was part of Captive Resources’ Medical Stop Loss (MSL) Webinar Series — a regular series of webinars to educate MSL group captive members. The thoughts and opinions expressed in these webinars are those of the presenters and do not necessarily reflect Captive Resources’ positions on any of the above topics.
